MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.intimp.2025.115450

Медицинская библиотека · International immunopharmacology · 2025

Amentoflavone as a dual-target inhibitor of IL11 signaling alleviates intervertebral disc fibrosis.

Chen Rongsheng, Chen Zhibin, Chen Yiping, Xu Boxuan, Su Min, Xu Weihong

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Fibrotic remodeling of the nucleus pulposus (NP) has been increasingly recognized as a key driver of intervertebral disc degeneration (IVDD), highlighting the role of fibroblast-like NP cells and myofibroblasts in excessive collagen deposition and tissue stiffening. Meanwhile, small-molecule compounds capable of modulating multiple pathological pathways have drawn growing attention in recent research, making them attractive candidates for IVDD treatment.

METHODS

We first analyzed the GSE27494 dataset to identify IL11 dysregulation in degenerated human NP tissues and performed KEGG pathway analysis. The expression of IL11 was then validated in human clinical samples and a mouse annulus fibrosus puncture (AFP)-induced IVDD model. In vitro, fibrotic NP cell models were established using bleomycin (BLM), and the effects of IL11 and its downstream signaling were assessed via western blot and immunofluorescence. Molecular docking was used to screen natural compounds targeting IL11RA and IL6ST. The top candidates, including amentoflavone (AMT), were tested in vitro and in vivo for anti-fibrotic efficacy.

RESULTS

IL11 expression was significantly upregulated in both human and murine degenerative discs. IL11 promoted the expression of fibrotic markers (COL1, α-SMA, PDGFR) and inflammatory cytokines (IL1β, IL6) in NP cells. Molecular docking identified AMT as a high-affinity dual-target inhibitor of IL11RA and IL6ST. AMT treatment reduced IL11 expression and downstream fibrosis in vitro, and attenuated IVDD progression, inflammatory cytokine expression, and fibrosis in the mouse model.

CONCLUSIONS

IL11 plays a pivotal role in the fibrotic remodeling of NP cells during IVDD. Amentoflavone suppresses IL11-driven fibrosis by targeting both IL11RA and IL6ST, offering a promising therapeutic strategy for IVDD.

Для цитирования: Chen Rongsheng, Chen Zhibin, Chen Yiping, Xu Boxuan, Su Min, Xu Weihong. Amentoflavone as a dual-target inhibitor of IL11 signaling alleviates intervertebral disc fibrosis.. International immunopharmacology. 2025. DOI: 10.1016/j.intimp.2025.115450.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.